BJDX vs EIX · rev $249.0K vs P/E 7.3, rev $17.60B
Bluejay Diagnostics Inc (BJDX) versus Edison International (EIX) — a side-by-side from cached financials, not a winner call.
Bluejay Diagnostics Inc (BJDX) is a medical devices company listed on US.
Edison International (EIX) is a utilities - regulated electric company listed on US.
Latest reported BJDX revenue for 2022-12-31 was $249.0K. Net income was -$9.3M. BJDX currently screens at market cap $5.0M.
Latest reported EIX revenue for 2024-12-31 was $17.60B. Net income was $1.55B. Revenue was up 7.7% from 2023-12-31 to 2024-12-31. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
BJDX currently screens at market cap $5.0M. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
Not investment advice. Open the BJDX and EIX stock pages for the full models.
Not investment advice.